Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure
by Mandi Murph, Director of Medical Education Introduction It’s a health risk many may not know exists – nail lamps.…
Blog - Melanoma360
10/08/2024
Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure
by Mandi Murph, Director of Medical Education Introduction It’s a health risk many may not know exists – nail lamps.…
10/01/2024
Summit of Survival: Tobi’s Journey Beyond Melanoma
In this episode, we are joined by Tobi Sample, a melanoma survivor, to share an extraordinary and inspiring story. Today,…
|
10/01/2024
Ways to Give: Monthly Giving
Sixth Article in a Series Are you familiar with The Supporters Guild, AIM’s Monthly Giving Program? It empowers you to…
|
09/24/2024
Social Awareness and Support Needed for Spouses of Patients Recently Diagnosed With Cancer
Understanding Emotional Distress After a Cancer Diagnosis For a patient recently diagnosed with cancer, mental or psychological distress is normal.…
09/20/2024
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin
How much is enough? Exploring excisional margins for in situ melanoma When a patient with melanoma in situ has a…
|
09/15/2024
Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab
There is good news for patients with melanoma who received immunotherapy. Survival results from a major clinical trial, CheckMate-067, show…
|
09/15/2024
Ten Years of Pembrolizumab Shows Sustained Results
There is good news for patients with advanced melanoma who received pembrolizumab. Results from a clinical trial after ten years…
|
09/15/2024
Oncolytic Virotherapy Shows Promise in Advanced Melanoma that Failed Immunotherapy
New clinical trial data shows that additional options may soon become available for patients with melanoma for whom immunotherapy did…
|
09/15/2024
New Therapies Under Investigation for Patients With Metastatic Uveal Melanoma
Results from a Phase 2 clinical trial for patients with advanced uveal melanoma were presented at ESMO 2024 on September…
|
09/14/2024
News from ESMO: NADINA Trial Update in Stage III Melanoma
A follow-up report with data from NADINA was presented at the European Society for Medical Oncology (ESMO) Congress on September…
|
Recent Posts
Nov. 22, 2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Nov. 22, 2024
Meaning-Centered Psychotherapy for Cancer Patients
Nov. 05, 2024
Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations
Nov. 04, 2024
Book Suggestions for Caregivers
Oct. 28, 2024